(R)-Irsenontrine

Overview

(R)-Irsenontrine ((R)-E2027), the R-enantiomer of Irsenontrine ( HY-132821 ), is a potent phosphodiesterase 9 ( PDE9 ) inhibitor with an IC 50 value of 0.041 μM. (R)-Irsenontrine can be used for the research of neurological diseases.

Application

Products | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Phosphodiesterase (PDE)

Product Information

• Catalog No.: HY-132821B
• CAS No.: 1429509-81-8
• Molecular Formula: C22H22N4O3
• Molecular Weight: 390.44
• Purity: 99.00%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Availability: In-stock

Source

Original product source